Aerie Pharmaceuticals reported $63.48M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aerie Pharmaceuticals AERI:US $ 63.48M 552K
Alimera Sciences ALIM:US $ 16.04M 666K
Amarin AMRN:US 122.94M 5.42M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Cara Therapeutics CARA:US $ 32.7M 1.64M
Coherus Biosciences CHRS:US $ 147.26M 34.34M
Endo International Ordinary Shares ENDP:US $ 583.27M 618.52M
Horizon Pharma HZNP:US $ 690.93M 90.45M
Insmed INSM:US $ 142.94M 12.26M
JAZZ PHA JAZZ:US $ 726.17M 121.18M
Merk MRK:US $ 10332M 386M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Novartis NOVN:VX 9.96B 998M
Ophthotech OPHT:US $ 34.67M 1.57M
Pacira Pharmaceuticals PCRX:US $ 140.6M 14.38M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Revance Therapeutics RVNC:US $ 87.48M 72K
Supernus Pharmaceuticals SUPN:US $ 150.54M 2.41M
Teva Pharmaceutical Industries TEVA:US 4.37B 352M
Valeant Pharmaceuticals VRX:CN C$ 1.63B 196M
Zoetis ZTS:US $ 1.26B 202M